Author

S. Madan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Organism:bacteria (other)· 1 Research Focus:benchmarking· 1

Frequent Co-Authors

E. Ruppin· 2 shared S. Sinha· 2 shared A. A. Lal· 1 shared A. A. Schaffer· 1 shared A. Erez· 1 shared A. P. Gupta· 1 shared A. Papanicolau-Sengos· 1 shared A. Poddar· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

E. Ruppin

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Charting the transcriptomic landscape of primary and metastatic cancers in relation to their origin and target normal tissues

N. Sanghvi, C. Calvo-Alcaniz, P. Rajagopal, S. Scalera, V. Canu, S. Sinha, F. Schischlik, K. Wang, S. Madan, E. Shulman, A. Papanicolau-Sengos, G. Blandino, E. Ruppin, N. Nair

The paper compares gene expression in primary and metastatic tumors to their origin and target tissues, finding metastases more resemble target tissues and show reduced cancer hallmark activity.

bioRxiv · Oct 30, 2023Cancer Biology

GroEL-proteotyping of bacterial communities by tandem mass spectrometry

S. Klaes, S. Madan, D. Deobald, M. Cooper, L. Adrian

The paper introduces GroEL-proteotyping, a method using tandem mass spectrometry to profile bacterial communities at the family level, validated on synthetic and human gut samples.

bioRxiv · Jul 3, 2023 · PreprintMicrobiology

Using a recently approved tumor mutational burden biomarker to stratify patients for immunotherapy may introduce a sex bias

N. Sinha, S. Sinha, K. Cheng, S. Madan, A. Erez, B. Ryan, A. A. Schaffer, K. Aldape, E. Ruppin

The paper investigates if using a high tumor mutational burden (TMB) threshold for immunotherapy selection introduces sex bias, finding significant bias in melanoma but not in other cancers.

bioRxiv · May 28, 2021Cancer Biology

Cocculus hirsutus -derived phytopharmaceutical drug has potent anti-dengue activity

A. Poddar, R. Shukla, H. Beesetti, U. Arora, R. K. Rajpoot, R. K. Shanmugam, S. Palla, K. Nayyar, D. Singh, V. Singamaneni, P. Gupta, A. P. Gupta, S. Gairola, Y. S. Bedi, T. Jain, , N. Khanna

This paper identifies Cocculus hirsutus-derived AQCH as a potent anti-dengue drug with in vitro and in vivo efficacy, characterized by five chemical markers and formulated into tablets for further development.

bioRxiv · Sep 18, 2020 · PreprintMicrobiology